Home » Topics » Regulatory

Regulatory
RSS

Tracleer fails to meet primary endpoints in phase III CHF study

Feb. 12, 2002

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Feb. 8, 2002

Xopenex approved for pediatric use in bronchospasm

Feb. 7, 2002

Once-daily one-tablet formulation of Sustiva approved

Feb. 6, 2002

First approval obtained for antihypertensive combination developed in Spain

Feb. 5, 2002

Gleevec approved for gastrointestinal stromal tumors

Feb. 5, 2002

Zometa receives positive opinion for treatment of cancer-related bone metastases

Feb. 4, 2002

Amgen's Neulasta approved for febrile neutropenia

Feb. 4, 2002

Guilford seeks expansion of indications for Gliadel in Europe

Feb. 4, 2002

Approvable letter received for use of Altocor in hypercholesterolemia

Feb. 4, 2002

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...